혈액암 체세포 변이의 해석과 보고에 대한 권고안

키워드

참고문헌 (23)

1. Li MM, "Standards and guidelines for the interpretation and reporting of sequence variants in cancer : a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists", J Mol Diagn, 19, pp.4~23 (2017)
2. Li MM, "Assessments of somatic variant classification using the Association for Molecular Pathology", American Society of Clinical Oncology, J Mol Diagn, pp.2023, 25[DOI]
3. Mateo J, "A framework to rank genomic alterations as targets for cancer precision medicine : the ESMO scale for clinical actionability of molecular targets(ESCAT)", Ann Oncol, 29, pp.1895~1902 (2018)
4. Griffith M, "CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer", Nat Genet, 49, pp.170~174 (2017)
5. Chakravarty D, "OncoKB : a precision oncology knowledge base", JCO Precis Oncol, 1, pp.1~16 (2017)
6. Wagner AH, "A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer", Nat Genet, 52, pp.448~457 (2020)
7. Horak P, "Standards for the classification of pathogenicity of somatic variants in cancer(oncogenicity) : joint recommendations of Clinical Genome Resource(ClinGen), Cancer Genomics Consortium(CGC), and Variant Interpretation for Cancer Consortium(VICC)", Genet Med, 24, pp.986~998 (2022)
8. Froyen G, "Standardization of somatic variant classifications in solid and haematological tumours by a two-level approach of biological and clinical classes : an initiative of the Belgian ComPerMed expert panel", Cancers(Basel), 11, pp.2030~ (2019)
9. Palomo L, "Spanish guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia", Br J Haematol, 188, pp.605~622 (2020)
10. Kim J, "Status of nextgeneration sequencing-based genetic diagnosis in hematologic malignancies in Korea(2017-2018)", Lab Med Online, 11, pp.25~31 (2021)
11. Chen S, "A genomic mutational constraint map using variation in 76, 156 human genomes", Nature, 625, pp.92~100 (2024)
12. Lek M, "Analysis of protein-coding genetic variation in 60, 706 humans", Nature, 536, pp.285~291 (2016)
13. Auton A, "A global reference for human genetic variation", Nature, 526, pp.68~74 (2015)
14. Jung KS, "KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing", Database (Oxford), 2020, pp.baz146~ (2020)
15. McLeod C, "St. Jude Cloud : a pediatric cancer genomic data-sharing ecosystem", Cancer Discov, 11, pp.1082~1099 (2021)
16. Bamford S, "The COSMIC(catalogue of somatic mutations in cancer)database and website", Br J Cancer, 91, pp.355~358 (2004)
17. Khoury JD, "The 5th edition of the World Health Organization classification of haematolymphoid tumours : myeloid and histiocytic", dendritic neoplasms, 2022, pp.36, 1703~1719
18. Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~423 (2015)
19. Sukhai MA, "A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer", Genet Med, 18, pp.128~136 (2016)
20. Döhner H, "Diagnosis and management of AML in adults : 2022 recommendations from an international expert panel on behalf of the ELN", Blood, 140, pp.1345~1377 (2022)
21. Wang L, "ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen", Aging(Albany NY), 13, pp.22286~22297 (2021)
22. Fujino T, "ASXL1 mutation in clonal hematopoiesis", Exp Hematol, 83, pp.74~84 (2020)
23. Wakita S, "Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia", Blood Adv, 6, pp.238~247 (2022)

관련 논문AI추천